Transitioning to optimized correction with the wavelight ALLEGRETTO WAVE: Case distribution, visual outcomes, and wavefront aberrations

Journal of Refractive Surgery

Volumn 26, Issue 10, 2010, Pages

  George, Michael R ^a   Shah, Ravindra A ^a   Hood, Christopher ^a   Krueger, Ronald R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; EYE; HUMAN; HYPERMETROPIA; KERATOMETRY; LASER EPITHELIAL KERATOMILEUSIS; MEDICAL RECORD REVIEW; MYOPIA; NOMOGRAM; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

CORNEAL WAVEFRONT ABERRATION; HUMANS; HYPEROPIA; INTRAOPERATIVE COMPLICATIONS; KERATOMILEUSIS, LASER IN SITU; LASERS, EXCIMER; MYOPIA; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE COMPLICATIONS; REFRACTION, OCULAR; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 78449234902     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081597X-20100921-07     Document Type: Article

References (7)

1. Summary of Safety and Effectiveness for a Premarket Approval Application (for the wavefront-optimized correction of myopia with the ALLEGRETTO WAVE). Available at: http://www. accessdata.fda.gov/cdrh-docs/pdf2/P020050b.pdf. Accessed January 2010.
2. Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (for the wavefront-optimized correction of hyperopia with the ALLEGRETTO WAVE). Available at: http://www.accessdata.fda.gov/cdrh-docs/ pdf3/P030008b.pdf. Accessed January 2010.
3. Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (for the wavefront-optimized correction of myopia with the ALLEGRETTO WAVE). Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf2/ P020050S004b.pdf. Accessed January 2010.
4. Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (for the wavefront-guided correction of myopia with the ALLEGRETTO WAVE). Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf3/ P030008S004b.pdf. Accessed January 2010.
5. Stonecipher KG, Kezirian GM. Wavefront-optimized versus wavefront-guided LASIK for myopic astigmatism with the ALLEGRETTO WAVE: three-month results of a prospective FDA trial. J Refract Surg. 2008;24(4):S424-S430.
6. Ghoreishi SM, Naderibeni A, Peyman A, Rismanchian A, Eslami F. Aspheric profile versus wavefront-guided ablation photorefractive keratectomy for the correction of myopia using the Allegretto Eye Q. Eur J Ophthalmol. 2009;19(4):544-553.
7. Hood C, Krueger RK, Wilson SE. The effect of femtosecond laser flap thickness and flap diameter on wavefront aberrations after customized LASIK. Poster presented at: Association for Research in Vision and Ophthalmology Annual Meeting; May 2-6, 2010; Ft Lauderdale, Florida.